Denmark· DK-28103041598
Trileptal
A oxcarbazepine product containing oxcarbazepin, registered in Denmark by Novartis Healthcare A/S. The same ATC class is registered in 15 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Oxcarbazepine is registered in 15 of 19 countries.
Countries holding a registration under ATC N03AF02 (oxcarbazepine), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 9 of them publish a price we can compare per daily dose
Oxcarbazepine · ATC N03AF02
15 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of oxcarbazepine costs, country by country.
Normalised to the WHO defined daily dose (1 g), the median price runs from $0.56 in United States to $2.54 in Switzerland — a ×4.5 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Oxcarbazepine · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.54
- FR France$1.08
- IT Italy$0.73
- US United States$0.56 (acquisition cost)
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- OXCARBAZEPIN
- Manufacturer
- Novartis Healthcare A/S
- Country
- Denmark (DK)
- ATC code
- N03AF02
- ATC class
- Oxcarbazepine
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28103041598
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
398 interactions on record for oxcarbazepine.
Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Oxcarbazepine · interactions on record
398 records
- 8 severe
- 263 moderate
- 7 minor
- 72 info
Most severe, free to view
- Levonorgestrel and ethinylestradiolG03AA07severe
- Desogestrel and ethinylestradiolG03AA09severe
- Drospirenone and ethinylestradiolG03AA12severe
- EthinylestradiolG03CA01severe
48 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under N03AF02
Oxcarbazepine, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f9f55a74-b4c8-4331-9e4d-af74167a209b GET /v1/drugs/f9f55a74-b4c8-4331-9e4d-af74167a209b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "filmovertrukne tabletter",
"source": "dkma",
"strength": "600 mg",
"auth_role": "RMS",
"dk_drugid": "28103041598",
"substance": "OXCARBAZEPIN",
"auth_procedure": "MRP",
"in_medicinpriser": true,
"registration_date_serial": "36382"
}See everything about oxcarbazepine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.